Drug Shortage Report for APO-NAPROXEN

Last updated on 2017-11-09 History
Report ID 16881
Drug Identification Number 00592277
Brand name APO NAPROXEN TAB 500MG
Common or Proper name NAPROXEN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) NAPROXEN
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500 BTL
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-12-18
Actual start date
Estimated end date
Actual end date 2017-11-08
Shortage status Avoided shortage
Updated date 2017-11-09
Company comments 100 BTL available
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2017-11-09 French Compare
v7 2017-11-09 English Compare
v6 2017-10-10 French Compare
v5 2017-10-10 English Compare
v4 2017-09-22 French Compare
v3 2017-09-22 English Compare
v2 2017-07-25 French Compare
v1 2017-07-25 English Compare

Showing 1 to 8 of 8